New Hampshire 2026 Session Status: Enacted Bipartisan · 6 D · 3 R cosponsors

HB 1318 — renewing the committee to study non-pharmacological treatment options for patients with chronic pain.

Last action — Signed by Governor Ayotte 06/19/2026; Chapter 164; eff. 06/19/2026

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. ✓
    Passed House
  4. ✓
    Passed Senate
  5. ✓
    To Executive
  6. 6
    Enacted

This bill has been enacted into law. Introduced December 01, 2025. Enacted.

Signed by Governor Kelly Ayotte (Republican) on June 24, 2026.

Odds of enactment

High chance

Based on the sponsor, cosponsors, and committee posture, this bill has a high chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Likely to advance 78% · moderate confidence

  • Enacted

    Current position in the legislative process.

  • 9 sponsors

    1 primary, 8 co-sponsors signed on.

  • Bipartisan support

    Sponsored across 2 parties (6 D · 3 R) — cross-party backing.

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

In plain language

The bill renews a committee to study non-drug treatments for chronic pain.

This bill renews the committee focused on exploring non-pharmacological treatment options for individuals dealing with chronic pain. The aim is to investigate alternatives to medication for managing pain effectively.

What this means for you
  • Healthcare: For healthcare providers, this means potential new options and guidelines for treating patients with chronic pain.

Summary

renewing the committee to study non-pharmacological treatment options for patients with chronic pain. 

Bill Text

What changed in the latest version

24 added · 21 removed

Plain-language change summary

The updated version of HB 1318 extends the work of the committee studying non-drug treatments for chronic pain, allowing it to continue until 2028 instead of 2025. Additionally, it emphasizes the importance of finding new payment methods to support innovative care approaches, based on findings from previous meetings. This matters because it highlights a growing recognition of non-pharmacological treatments, which could lead to more effective pain management strategies for patients without relying solely on medications.

→
Previous
Latest
HB 1318 - VERSION ADOPTED BY BOTH BODIES 04/16/2026 1424s SESSION 26-2967 05/08 HOUSE BILL 1318 AN ACT renewing the committee to study non-pharmacological treatment options for patients with chronic pain.  SPONSORS:
CHAPTER 164 HB 1318 - FINAL VERSION 04/16/2026 1424s SESSION 26-2967 05/08 HOUSE BILL 1318 AN ACT renewing the committee to study non-pharmacological treatment options for patients with chronic pain.  SPONSORS:
HB 1318 - VERSION ADOPTED BY BOTH BODIES 04/16/2026 1424s 26-2967 05/08 STATE OF NEW HAMPSHIRE In the Year of Our Lord Two Thousand Twenty-Six AN ACT renewing the committee to study non-pharmacological treatment options for patients with chronic pain.  Be it Enacted by the Senate and House of Representatives in General Court convened:
CHAPTER 164 HB 1318 - FINAL VERSION 04/16/2026 1424s 26-2967 05/08 STATE OF NEW HAMPSHIRE In the Year of Our Lord Two Thousand Twenty-Six AN ACT renewing the committee to study non-pharmacological treatment options for patients with chronic pain.  Be it Enacted by the Senate and House of Representatives in General Court convened:
1  Findings.
164:1  Findings.
  The general court finds that during 2023, 2024, and 2025 meetings, the committee to study non-pharmacological treatment options for patients with chronic pain established that a patient-centric, integrated model of care is a credible and practical foundation upon which to build a pilot program.
  The general court finds that during 2023, 2024, and 2025 meetings, the committee to study non-pharmacological treatment options for patients with chronic pain established that a patient- centric, integrated model of care is a credible and practical foundation upon which to build a pilot program.
2   Extension of the Committee to Study Non-pharmacological Treatment Options for Patients with Chronic Pain.
164:2   Extension of the Committee to Study Non-pharmacological Treatment Options for Patients with Chronic Pain.
3  Effective Date.
164:3  Effective Date.
Approved:
June 19, 2026 Effective Date:
June 19, 2026
⬇ Download PDF
View plain text versions (4)

Action History

  1. Signed by Governor Ayotte 06/19/2026; Chapter 164; eff. 06/19/2026

  2. Enrolled (in recess of) 06/04/2026 HJ 15

  3. Enrolled Adopted, VV, (In recess 06/04/2026); SJ 14

  4. House Concurs with Senate Amendment 2026-1424s (Reps. W. MacDonald, Janigian): MA VV 05/07/2026 HJ 12

  5. Committee Report: Ought to Pass with Amendment # 2026-1424s, 04/16/2026; Vote 4-0; CC; SC 14A

  6. Committee Amendment # 2026-1424s, AA, VV; 04/16/2026; SJ 9

  7. Ought to Pass with Amendment # 2026-1424s, MA, VV; OT3rdg; 04/16/2026; SJ 9

  8. Hearing: 03/18/2026, Room 100, SH, 10:00 am; SC 10

  9. Introduced 03/05/2026 and Referred to Health and Human Services; SJ 6

  10. Ought to Pass: MA VV 03/05/2026 HJ 6 P. 19

  11. Committee Report: Ought to Pass 02/18/2026 (Vote 17-1; CC) HC 9 P. 16

  12. Executive Session: 02/18/2026 02:30 pm GP 158

  13. Public Hearing: 02/11/2026 10:00 am GP 158

  14. Introduced 01/07/2026 and referred to Health, Human Services and Elderly Affairs HJ 1 P. 15

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 8 co-sponsors · 406 not signed on

Sponsors (1)

Co-sponsors (8)

Not signed on (406)

406 members have not signed on to this bill.

Show all 406 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HB 1318 do?
renewing the committee to study non-pharmacological treatment options for patients with chronic pain. 
Who sponsors HB 1318?
HB 1318 is sponsored by Julie Miles (Republican), Trinidad Tellez (Democrat), David Nagel (Democrat), Heath Howard (Democrat), Cindy Rosenwald (Democrat), David Watters (Democrat), David Lundgren (Republican), Gary Woods (Democrat), and Terry Roy (Republican).
What is the current status of HB 1318?
This bill has been enacted into law. Introduced December 01, 2025. Enacted.
Where can I track HB 1318?
Track HB 1318 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB 1318

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HB 1318

Last checked for changes about 1 month ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →